Abdominal adhesions: current and novel therapies

BC Ward, A Panitch - Journal of Surgical Research, 2011 - Elsevier
An adhesion occurs when two tissues that normally freely move past each other attach via a
fibrous bridge. Abdominal adhesions place a tremendous clinical and financial burden on …

Polymers for cell/tissue anti-adhesion

E Lih, SH Oh, YK Joung, JH Lee, DK Han - Progress in polymer science, 2015 - Elsevier
The appropriate anti-adhesive effect of polymers on cells or tissues in the body is one of the
essential requirements of maintaining health and protecting the body from trauma and …

Inhibition of hyperglycolysis in mesothelial cells prevents peritoneal fibrosis

M Si, Q Wang, Y Li, H Lin, D Luo, W Zhao… - Science translational …, 2019 - science.org
Progressive peritoneal fibrosis affects patients receiving peritoneal dialysis (PD) and has no
reliable treatment. The mechanisms that initiate and sustain peritoneal fibrosis remain …

Novel aspects of the immune response involved in the peritoneal damage in chronic kidney disease patients under dialysis

F Trionfetti, V Marchant, GT González-Mateo… - International Journal of …, 2023 - mdpi.com
Chronic kidney disease (CKD) incidence is growing worldwide, with a significant percentage
of CKD patients reaching end-stage renal disease (ESRD) and requiring kidney …

Restoration of WT1/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells

G Bontempi, M Terri, S Garbo, C Montaldo… - Cell Death & …, 2022 - nature.com
Histone acetylation/deacetylation play an essential role in modifying chromatin structure and
in regulating cell plasticity in eukaryotic cells. Therefore, histone deacetylase (HDAC) …

miR‐9‐5p suppresses pro‐fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX 4 and TGFBR 2

M Fierro‐Fernández, Ó Busnadiego, P Sandoval… - EMBO …, 2015 - embopress.org
Uncontrolled extracellular matrix (ECM) production by fibroblasts in response to injury
contributes to fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Reactive …

Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-κB/Snail1 pathway

R Strippoli, I Benedicto… - Disease models & …, 2008 - journals.biologists.com
Epithelial-to-mesenchymal transition (EMT) occurs in fibrotic diseases affecting the kidney,
liver and lung, and in the peritoneum of patients undergoing peritoneal dialysis. EMT in the …

Caveolin‐1 deficiency induces a MEK‐ERK 1/2‐Snail‐1‐dependent epithelial–mesenchymal transition and fibrosis during peritoneal dialysis

R Strippoli, J Loureiro, V Moreno… - EMBO molecular …, 2015 - embopress.org
Peritoneal dialysis (PD) is a form of renal replacement therapy whose repeated use can alter
dialytic function through induction of epithelial–mesenchymal transition (EMT) and fibrosis …

Mesenchymal conversion of mesothelial cells is a key event in the pathophysiology of the peritoneum during peritoneal dialysis

M López-Cabrera - Advances in medicine, 2014 - Wiley Online Library
Peritoneal dialysis (PD) is a therapeutic option for the treatment of end‐stage renal disease
and is based on the use of the peritoneum as a semipermeable membrane for the exchange …

[PDF][PDF] Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment

SM Habib, MG Betjes, MW Fieren, EW Boeschoten… - Neth J Med, 2011 - njmonline.nl
1Department of Internal Medicine, Erasmus Medical Centre, Rotterdam, the Netherlands,
2Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands …